CVE-2020-16212: Philips Patient Monitoring Devices Exposure of Resource to Wrong Sphere
In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the product exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource. The application on the surveillance station operates in kiosk mode, which is vulnerable to local breakouts that could allow an attacker with physical access to escape the restricted environment with limited privileges.
Other sources
Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, PerformanceBridge Focal Point Version A.01, IntelliVue patient monitors MX100, MX400-MX850, and MP2-MP90 Versions N and prior, IntelliVue X3 and X2 Versions N and prior. The product exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource. The application on the surveillance station operates in kiosk mode, which is vulnerable to local breakouts that could allow an attacker with physical access to escape the restricted environment with limited privileges.
Affected Software
Remediation
Information
Event History
Frequently Asked Questions
What is the severity of CVE-2020-16212?
The severity of CVE-2020-16212 is medium with a CVSS score of 6.8.
Which software versions are affected by CVE-2020-16212?
The affected software versions are B.02, C.02, and C.03 of Philips Patient Information Center iX (PICiX).
How does CVE-2020-16212 impact patient monitors?
CVE-2020-16212 exposes a resource to the wrong control sphere, potentially compromising the security of IntelliVue patient monitors MX100, MX400-MX850, and MP2-MP90 Versions N and prior, IntelliVue X3 and X2 Versions N and prior.
Is there a fix for CVE-2020-16212?
A fix for CVE-2020-16212 may be available from Philips. Please refer to their official advisories for guidance on applying the necessary patches or updates.
Where can I find more information about CVE-2020-16212?
You can find more information about CVE-2020-16212 on the official advisory published by US-CERT at https://us-cert.cisa.gov/ics/advisories/icsma-20-254-01.